Schonfeld Strategic Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-189,671
Closed -$7.99M 2485
2023
Q2
$7.99M Buy
189,671
+180,971
+2,080% +$7.32M 0.07% 397
2023
Q1
$310K Buy
+8,700
New +$316K ﹤0.01% 1369
2022
Q4
Sell
-55,724
Closed -$2.63M 3183
2022
Q3
$2.63M Buy
+55,724
New +$3.6M 0.02% 756
2021
Q3
Sell
-227,554
Closed -$20.4M 2575
2021
Q2
$20.4M Buy
227,554
+113,674
+100% +$9.6M 0.22% 123
2021
Q1
$8.64M Buy
113,880
+99,398
+686% +$7.49M 0.11% 265
2020
Q4
$987K Buy
+14,482
New +$903K 0.01% 819
2019
Q1
Sell
-82,897
Closed -$3.26M 1360
2018
Q4
$3.26M Sell
82,897
-30,203
-27% -$1.4M 0.13% 227
2018
Q3
$5.83M Buy
113,100
+12,300
+12% +$602K 0.26% 109
2018
Q2
$4.73M Buy
+100,800
New +$4.17M 0.26% 130
2016
Q3
Sell
-7,374
Closed -$282K 586
2016
Q2
$282K Buy
+7,374
New +$324K 0.06% 325

Other funds holding SYNH

Schonfeld Strategic Advisors's SYNH Position: Q3 2023 in Review

Schonfeld Strategic Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 189,671 shares — an estimated $7.99M sold.

Schonfeld Strategic Advisors first reported a position in SYNH in Q2 2016 and held it in 10 quarters. The position peaked at $20.4M in Q2 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Schonfeld Strategic Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 189,671 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $7.99M.
  • Schonfeld Strategic Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2016 and held it in 10 quarters.
  • Schonfeld Strategic Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $20.4M in Q2 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.